Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
More About the Unwanted Inheritance
The latest research confirms that epigenetic changes are involved in substance use disorders. It would not be surprising to find them accountable for most of what we characterize as addiction.
The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.
Too Much of a Good Thing?
When impulsivity crosses over into genuine inadequately-considered risk-taking, it may be a good time to hit the brakes — and sometimes we can’t.
Can Dopamine Homeostasis Be Achieved?
Is it possible that the restoration of a person’s dopamine homeostasis, through administration of tailored neuronutrients, could free them from all addictions in one masterful and definitive stroke?
Online Shopping Addiction and Compulsive Buying
Award-winning journalist, Emma Marris, travels the world following the science of shopping addiction and compulsive buying.